EMAIL THIS PAGE TO A FRIEND

International journal of pharmaceutics

Biocompatibility of poly(D,L-lactic-co-hydroxymethyl glycolic acid) microspheres after subcutaneous and subcapsular renal injection.


PMID 25497444

Abstract

Poly(D,L-lactic-co-hydroxymethyl glycolic acid) (PLHMGA) is a biodegradable copolymer with potential as a novel carrier in polymeric drug delivery systems. In this study, the biocompatibility of PLHMGA microspheres (PLHMGA-ms) was investigated both in vitro in three different cell types (PK-84, HK-2 and PTECs) and in vivo at two implantation sites (by subcutaneous and subcapsular renal injection) in rats. Both monodisperse (narrow size distribution) and polydisperse PLHMGA-ms were prepared with volume weight mean diameter of 34 and 17 μm, respectively. Mono and polydisperse PLHMGA-ms showed good cytocompatibility properties upon 72 h incubation with the cells (100 μg microspheres/600 μL/cell line). A mild foreign body reaction was seen shortly after subcutaneous injection (20 mg per pocket) of both mono and polydisperse PLHMGA-ms with the presence of mainly macrophages, few foreign body giant cells and myofibroblasts. This transient inflammatory reaction diminished within 28 days after injection, the time-point at which the microspheres were degraded. The degradation profile is comparable to the in vitro degradation time of the microspheres (i.e., within 35 days) when incubated at 37 °C in phosphate buffered saline. Subcapsular renal injection of monodisperse PLHMGA-ms (10 mg) in rats was characterized with similar inflammatory patterns compared to the subcutaneous injection. No cortical damage was observed in the injected kidneys. In conclusion, this study demonstrates that PLHMGA-ms are well tolerated after in vivo injection in rats. This makes them a good candidate for controlled delivery systems of low-molecular weight drugs as well as protein biopharmaceuticals.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

240559
1,4-Butanediol, ReagentPlus®, ≥99%
C4H10O2
493732
1,4-Butanediol, ReagentPlus®, 99%
C4H10O2
102369
1,4-Dinitrobenzene, 98%
C6H4N2O4
442250
1,4-Dinitrobenzene, analytical standard
C6H4N2O4
151858
Chloroform-d, "100%", 99.96 atom % D
CCl3D
494275
Chloroform-d, "100%", 99.96 atom % D, contains 0.03 % (v/v) TMS
CCl3D
431915
Chloroform-d, "100%", 99.96 atom % D, contains 0.5 wt. % silver wire as stabilizer
CCl3D
151823
Chloroform-d, 99.8 atom % D
CCl3D
225789
Chloroform-d, 99.8 atom % D, contains 0.03 % (v/v) TMS
CCl3D
612200
Chloroform-d, 99.8 atom % D, contains 0.05 % (v/v) TMS
CCl3D
434876
Chloroform-d, 99.8 atom % D, contains 0.1 % (v/v) TMS
CCl3D
151831
Chloroform-d, 99.8 atom % D, contains 1 % (v/v) TMS
CCl3D
416754
Chloroform-d, ≥99.8 atom % D, contains 0.5 wt. % silver foil as stabilizer
CCl3D
530735
Chloroform-d, ≥99.8 atom % D, contains 0.5 wt. % silver foil as stabilizer, 0.03 % (v/v) TMS
CCl3D
570699
Chloroform-d, ≥99.8 atom % D, anhydrous
CCl3D
63560
D-Mannitol, ACS reagent, for microbiology, ≥99.0%
C6H14O6
17311
D-Mannitol, tested according to Ph.Eur.
C6H14O6
78513
D-Mannitol, ≥99.9999% (metals basis), for boron determination
C6H14O6
PHR1007
Mannitol, Pharmaceutical Secondary Standard; Certified Reference Material
C6H14O6
1375105
Mannitol, United States Pharmacopeia (USP) Reference Standard
C6H14O6
13900
O-Benzyl-L-serine, ≥99.0% (NT)
C10H13NO3
38364
Phosphate Standard for IC, TraceCERT®, 1000 mg/L phosphate in water
HNa2O4P
71642
Sodium phosphate dibasic, purum p.a., anhydrous, ≥98.0% (T)
HNa2O4P
71496
Sodium phosphate monobasic, purum p.a., anhydrous, ≥99.0% (T)
H2NaO4P
S3252
Tin(II) 2-ethylhexanoate, 92.5-100.0%
C16H30O4Sn